Development of rheumatoid nodules during anti-tumor necrosis factor α therapy with etanercept

被引：61

作者：

Kekow, J ^{[1
]}

Welte, T ^{[1
]}

Kellner, U ^{[1
]}

Pap, T ^{[1
]}

机构：

[1] Otto Von Guericke Univ, Magdeburg, Germany

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1002/art.10096

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：843 / 844

页数：2

共 12 条

[1]

Bloom BJ, 2000, ARTHRITIS RHEUM, V43, P2606, DOI 10.1002/1529-0131(200011)43:11<2606::AID-ANR31>3.0.CO

[2]

2-X

[3]

Galaria NA, 2000, J RHEUMATOL, V27, P2041

[4] PRELIMINARY CRITERIA FOR CLINICAL REMISSION IN RHEUMATOID-ARTHRITIS [J].

PINALS, RS ;

MASI, AT ;

LARSEN, RA .

ARTHRITIS AND RHEUMATISM, 1981, 24 (10) :1308-1315

[5]

Reiff A, 2001, ARTHRITIS RHEUM, V44, P1411, DOI 10.1002/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO

[6]

2-O

[7] Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis [J].

Seitzer, U ;

Swider, C ;

Stuber, F ;

Suchnicki, K ;

Lange, A ;

Richter, E ;

Zabel, P ;

MullerQuernheim, J ;

Flad, HD ;

Gerdes, J .

CYTOKINE, 1997, 9 (10) :787-790

[8]

Stone JH, 2001, ARTHRITIS RHEUM, V44, P1149, DOI 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO

[9]

2-F

[10]

Wikaningrum R, 1998, ARTHRITIS RHEUM, V41, P1783, DOI 10.1002/1529-0131(199810)41:10<1783::AID-ART10>3.3.CO

← 1 2 →